Respiratory (Pleural diseases and lung cancer) Flashcards

1
Q

pneumothorax

A

collection of air in the pelural space

can be primary or secondary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Primary spontaneous pneumothorax

A

These occur in people without lung disease, however, there are risk factors:

  • Smoking
  • Male sex
  • Family history
  • Tall and slender build, especially people with Marfan’s syndrome
    *
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Secondary spontaneous pneumothorax

A

These occur in people who have lung disease. Risk factors are:

  • Asthma
  • COPD
  • Idiopathic pulmonary fibrosis
  • Connective tissue diseases such as rheumatoid arthritis
  • Tuberculosis
  • Pneumocystis jirovecii pneumonia in people who have HIV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

other causes of pneumothorax

A

Traumatic pneumothorax:

  • Often following penetrating chest trauma (e.g. stabbing, gunshots, fractured ribs)

Iatrogenic pneumothorax:

  • Common causes are mechanical ventilation, central line placement, and lung biopsy

Catamenial pneumothorax – pneumothorax at the time of menstruation

  • Due to thoracic endometriosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

presentation of pneumothorax

A
  • Dyspnoea
  • Pleuritic chest pain: This is chest pain that is worse when breathing in
  • Tachypnoea

Examination may show:
* Ipsilateral reduced breath sounds
* Ipsilateral hyper-resonance on percussion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

pneumothorax: severe signs of respiratory distress and haemodynamic instability may suggest

A

presence of tension pnuemothorax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

pathophysiology of tension pneumothorax

A

In a tension pneumothorax, injured pleural tissue leads to the formation of a one-way valve. This allows air to enter the pleural space during inspiration, but it cannot escape during expiration, leading to an increase in intrathoracic pressure.

** Obstructive circulatory** shock follows, where the heart, lungs, and major blood vessels are compressed, leading to haemodynamic compromise.

Risk factors are similar to that of a pneumothorax, along with blunt or penetrating chest trauma (such as knife stabbings).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

presentation of tension pneumothorax

A

haemodynamic instability should

  • Tracheal deviation away from the affected side – due to increasing intrathoracic pressure as more air enters
  • Signs of respiratory distress:
  • Hypotension – due to cardiac outflow obstruction
  • Tachycardia – due to the heart trying to compensate for outflow obstruction
  • Altered levels of consciousness
  • Sweating
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

investigations for normal pneumothorax

A

Chest x-ray(posteroanterior):
* Done initially and shows a visible rim between the lung margin and chest wall and absent lung markings between the lung margin and chest wall

Chest CT:
* Considered if the diagnosis is uncertain or there is a complex case

Arterial blood gases:
* Should only be done if oxygen saturations are <92%
* Usually shows hypoxia depending on the severity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

investigation for tension pneumothorax

A

nil- straight to needle decompression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

classification of size of pneumothorax

A

The size of the pneumothorax affects the rate of resolution and is used to guide whether management is carried out. The distance between the pleural surface and the lung edge is measured at the level of the hilum:

If ≤2cm – small pneumothorax
If >2cm – large pneumothorax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Management: Primary pneumothorax

A

Always remember to rule out a tension pneumothorax.

  • If <2cm and patient is not short of breath: discharge and review as an outpatient
  • If >2cm and/or patient is short of breath: Attempt aspiration. If aspiration fails, insert a chest drain

-> 2nd intercostal muscle or triangle of safety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Management: Secondary pneumothorax

A
  • If >50 years old + >2cm and/or patient is short of breath: insert a chest drain
  • If 1-2cm: attempt aspiration
  • If aspiration fails, insert a chest drain
  • If <1cm: give oxygen and admit for 24 hours and review
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

management of recurrent pneumothorax

A

pleurectomy, pleural abrasion and pleurodesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

management of tension pneumothorax

A
  1. Immediate decompression + high flow oxygen– insert a large-bore cannula through the second intercostal space in the mid-clavicular line:
    * A ‘hiss’ of air arising can confirm the diagnosis
  2. Insert chest drain immediately after decompression and admit to hospital: This is inserted into the ‘triangle of safety’ – mid-axillary line of the 5th intercostal space
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pleural effusion

A

When excessive fluid accumulates in the pleural space, this is known as a pleural effusion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

causes of pleural effusion can be split into

A

Transudate and Exudate

The causes of pleural effusion can be transudates or exudates depending on their protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

transudate

A

protein <30g/L

occurs due to increased hydrostatic pressure

  • congestive heart failure
  • cirrhosis
  • nephrotic syndrome
  • PE
  • hypoalbuminemia
  • Hypothyroidisms
  • Meigs syndrome
19
Q

exudate

A

protein >30g/l

occurs due to inflammation and increased capillary permeability
- pneumonia
- cancer
- TB
- PE
- autoimmune
- pancreatitis

20
Q

presentation of pleural effusion

A
  • Dyspnoea:
  • Dullness to percussion on examination:
  • Reduced breath sounds over the area of effusion
  • Pleuritic chest pain
  • Cough
  • Features of associated conditions such as heart failure
21
Q

pleural effusion investigations

A

Chest x-ray:

  • Shows blunting or blurring of the costophrenic angles
  • Shows a clear fluid level
  • The trachea deviates away from the opacification

Thoracic ultrasound:

  • Useful for guiding thoracentesis and more specific than X-rays for detecting pleural effusions

CT with contrast:

  • To investigate underlying cause

Pleural aspiration + microscopy, culture, sensitivities, cytology, and biochemistry:
Done with ultrasound guidance

  • Exudates:
    Protein level >30 g/L
  • Transudates:
    Protein level <30 g/L
    If the protein level is borderline (between 25-35 g/L), use Light’s criteria (see below)
22
Q

Pleural Fluid Interpretation

A

Blood

  • Malignancy
  • Pulmonary embolism
  • Trauma

Pleural pH
Reduced pleural pH (<7.20) can be caused by:

  • Infection
  • Empyema
  • Malignancy
  • Connective tissue diseases – rheumatoid arthritis and systemic lupus erythematosus
  • Tuberculosis
  • Oesophageal rupture

Pleural glucose

Reduced pleural glucose (<3.3 mmol/L) can be caused by:

  • Empyema
  • Malignancy
  • Connective tissue diseases – rheumatoid arthritis and systemic lupus erythematosus
  • Tuberculosis
  • Oesophageal rupture

Other measures

  • White cell count and differential: Elevated counts suggest malignancy or tuberculosis
  • Lactate dehydrogenase (LDH): Used in Light’s criteria (see below)
  • Pleural fluid amylase: Elevated counts suggest pancreatitis or oesophageal rupture
23
Q

Light’s criteria for pleural effusion

A

Light’s criteria should be used if the pleural fluid protein level is between 25-35 g/L. An exudate is likely if any one of the following applies:

  • Pleural fluid divided by serum protein is >0.5
  • Pleural fluid LDH divided by serum LDH >0.6
  • Pleural fluid LDH more than 2/3s of the upper limit of normal serum LDH
24
Q

management of pleural effusion

A
  • 1st-line: pleural aspiration:
    This is involved in diagnosing and identifying the underlying cause of the effusion and may provide therapeutic relief, however, the effusion can often recur
  • Chest drains may be inserted which are then removed once the underlying cause has been treated
  • Other options include surgical shunts, indwelling drainage catheters, or pleurodesis (adhesion of the visceral and parietal pleura)
25
Q

lung cancers are usually

A

bronchial carcinomas
* Non-small cell lung cancers (NSCLCs) – around 85% of cases
* Small cell lung cancers (SCLCs) – around 15% of cases

26
Q

Lung cancer metastases are common and typical sites are

A

the bone, kidney, breast, prostate, GI tract, ovaries, and cervix.

27
Q

Non-small cell lung cancers (NSCLCs)

They can be further divided into:

A

1) Adenocarcinoma
2)
* Most common type
* Often seen in non-smokers
* Lung periphery

2) Squamous carcinoma (smoking key risk factor)
3)
* Often presents as an obstruction of the bronchus leading to infection

3) Large cell carcinoma

4) Carcinoid tumours - flushing, diarrhoea

28
Q

Small cell lung cancers (SCLCs)

A

Small cell lung cancers (SCLCs) arise from Kulchitsky cells which are part of the amine precursor uptake and decarboxylation (APUD) system. APUD cells make polypeptides and amines that act as hormones or neurotransmitters. SCLCs often have paraneoplastic features (see below) as a result of this.

Smoking key RF

SCLCs carry a poor prognosis as they are aggressive and rapidly growing. They often spread early and are nearly always inoperable at presentation.

29
Q

Risk Factors of lung cancers

A
  • Active or passive smoking
  • Chronic obstructive pulmonary disease (COPD)
  • Increased age
  • Family history
  • Asbestos exposure
30
Q

presentation of lung cancer

A
  • Dyspnoea
  • Cough
  • Haemoptysis- red flag
  • Unexplained weight loss- red-flag
  • Chest pain or discomfort
  • Hoarseness: some tumours, particularly Pancoast tumours (tumours of the apex of the lung) can press on the recurrent laryngeal nerve, leading to hoarseness
  • Horner’s syndrome
  • Features of paraneoplastic syndromes – see below
31
Q

Paraneoplastic syndromes of lung cancer

A

is a set of signs and symptoms emerging as a consequence of a tumour in the body, typically due to the production of molecules (such as hormones) by tumour cells, or the immune response against the tumour itself. Paraneoplastic syndromes vary depending on the type of lung cancer present.

32
Q

paraneoplastic syndrome: adenocarcinoma

A

Gynaecomastia due to ectopic hCG secretion:
The hCG acts as LH and stimulates the production of more oestrogen

33
Q

paraneoplastic syndrome: small cell arcinoma

A
  • Ectopic anti-diuretic hormone (ADH) secretion leading to a syndrome of inappropriate ADH secretion (SIADH) resulting in hyponatraemia
  • Ectopic adrenocorticotropic hormone (ACTH)secretion leading to features of Cushing’s syndrome
  • Lambert-Eaton myasthenic syndrome (LEMS) due to the formation of antibodies against voltage-gated calcium ion channels:
  • These are antibodies that are made against the tumour cell that happen to also act against voltage-gated calcium ion channels
34
Q

paraneoplastic syndrome: squamous cell carcioma

A
  • Parathyroid hormone-related protein (PTH-rp) secretion leading to hypercalcaemia
  • Ectopic thyroid-stimulating hormone secretion (TSH) leading to thyrotoxicosis
35
Q

Refer using a suspected cancer (2-week wait) pathway for lung cancer if:

A
  • There are chest x-ray features that suggest lung cancer
  • ≥40 years with unexplained haemoptysis
36
Q

when to offer x-ray

A

Offer an urgent chest x-ray within 2 weeks if patients have 2 or more of the following, or if they have ever smoked and have one of the following:

  • Cough
  • Fatigue
  • Shortness of breath
  • Chest pain
  • Weight loss
  • Appetite loss

Consider an urgent chest x-ray within 2 weeks if patients are ≥40 with any of the following:

  • Persistent or recurrent chest infections
  • Finger clubbing
  • Supraclavicular or persistent cervical lymphadenopathy
  • Chest signs suggestive of cancer
  • Thrombocytosis – this can be a marker for potential cancers
37
Q

investigations for lung cancer

A

Chest x-rays:
* The first investigation performed on all patients with suspected lung cancer

CT chest with contrast:
* The investigation of choice for lung cancer
* The contrast helps differentiate lymph nodes from blood vessels

Bronchoscopy:
* To allow a biopsy to be taken for histological diagnosis
* Positron emission tomography (PET)-

CT scan:
* Done in potentially curable patients to localise pathology

Bloods
- FBC- thrombocytosis
- LFT- mets
- UEs- hyponatraemia due to SIADH

Bone scan
- mets

CT or MRI or brain
- brain metastasis

38
Q

management of lung cancer

A

Management options are put in place using a multidisciplinary approach. In NSCLC, surgery may be an option, along with radiotherapy and chemotherapy. Many patients with SCLC, however, have metastases at the time of presentation, and are less suitable for surgery, leaving chemotherapy and radiotherapy as treatment options.

Treatments such as endobronchial stenting and debulking can be used in palliative care to relieve bronchial obstruction.

39
Q

Mesothelioma

A
  • Mesothelioma is a cancer that develops from the mesothelial lining of the lungs and is strongly associated with asbestos exposure.
  • Other less common sites that can be affected are the lining of the abdomen, the pericardium, or the tunica vaginalis surrounding the testes.
40
Q

Asbestos-Related Lung Diseases

A

Asbestos is a fibre-like material that was once used in insulating buildings. Its use has been fully banned since 1999. People exposed to asbestos often develop lung disease, and the risk of developing asbestos-related diseases increases with the duration and degree of exposure.

Asbestos exposure can lead to the development of:

Benign diseases:
* Pleural plaques – most common
* Pleural thickening

Interstitial lung disease:
* Asbestosis – usually causes lower lobe fibrosis

Malignant disease:
* Mesothelioma
* Lung cancer

41
Q

RF mesothelioma

A
  • Asbestos exposure
  • Age >75 years – this is because the latency period between asbestos exposure and the development of mesothelioma is around 20-40 years, so most patients are older adults
42
Q

presentation of mesothelioma

A

Mesothelioma should be suspected in a patient with new painless pleural effusions, especially if they have chest pain or a history of asbestos exposure. Patients may have:

  • Progressively worsening shortness of breath
  • Chest pain:
  • Cough: usually dry
  • Constitutional symptoms: These are fevers, night sweats, weight loss, and fatigue
  • Reduced breath sounds on examination:
  • Usually due to pleural effusions or obstruction
  • Dullness to percussion on examination:
  • Usually due to pleural effusions
43
Q

Investigations for mesothelioma

A

Chest x-ray:
* May show pleural effusions or pleural thickening
* There may also be signs of asbestos exposure e.g. lower zone lung fibrosis

CT chest with contrast:
* More sensitive for identifying mesothelioma

Pleural fluid analysis:
* If a pleural effusion is present, the fluid should be sent for microscopy, culture and sensitivities, biochemistry, and cytology

Pleural biopsy via thoracoscopy
- Allows for histological diagnosis

44
Q
A